Linden Asset logo

Linden Asset

Asia, Shanghai, China, Shanghai

Description

Linden Asset is an investment firm.

Investor Profile

Linden Asset has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (67%)
  • Series D (33%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Genetics
  • Life Science
  • Medical
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Linden Asset frequently co-invest with?

New Frontier Health
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Co-Investments: 1
DC
North America, Arizona, United States, Scottsdale
Co-Investments: 1
Jinyi Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Innolink Fund
Asia, Beijing, China, Haidian
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 1
Chimera Investment
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 1
Keyuan Industry Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
MF
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Linden Asset?

Abogen Biosciences

Suzhou, Jiangsu, China

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

BiotechnologyGeneticsLife Science
Series CNov 29, 2021
Amount Raised: $300,000,000
Pulse Medical Technology

Shanghai, Shanghai, China

Pulse Medical Technology develops innovative technology for the diagnosis and optimal treatment of pan-vascular diseases.

Health CareHealth DiagnosticsMedical Device
Series CAug 2, 2021
Amount Raised: $100,000,000
Hanyu Medical

Shanghai, Shanghai, China

Hanyu Medical is a transcatheter mitral valve repair equipment supplier.

Health CareMedicalMedical Device
Series DMar 15, 2021
Amount Raised: $76,924,260